Amantadine preserve VCAM immunoexpression levels in cardiac injury induced by brain trauma with its anti-inflammatory action and protective effect on the mitochondrial membrane

Year 2024, , 15 - 23, 28.12.2024

Özlem Özmen , Halil Aşçı , Mehtap Savran , Melda Şahin , Hüseyin Dolu

https://doi.org/10.24998/maeusabed.1593256

Abstract

Brain trauma-induced cytokine storms can impact multiple organs, particularly the heart, through inflammatory and apoptotic mechanisms. This study aimed to examine cardiac pathology following experimental brain trauma (BTCI) and evaluate the protective effects of amantadine (AMN), an NMDA receptor antagonist, on cardiotoxicity. Forty rats were divided into four groups: sham, BTCI, BTCI+AMN-1 (45 mg/kg, ip), and BTCI+AMN-7. Trauma (0.2 Newton) was induced by dropping a 50 g ball from 80 cm. Heart samples were collected 24 hours and seven days post-trauma for histopathological and immunohistochemical analysis. The BTCI group showed hyperemia, hemorrhage, inflammatory infiltrations, increased Bax and VCAM expressions, and decreased Bcl-2 expression. AMN treatment reversed these findings, with greater efficacy observed after seven days. In conclusion, BTCI induces cardiac damage, while AMN provides protective effects. Further studies are needed to clarify underlying mechanisms.

Keywords

Brain trauma, heart, VCAM, Bax, Bcl2, inflammation

Project Number

Süleyman Demirel University Scientific Research Coordination Unit "project code: TSG-2023-9092.

References

• Abdelbaky, A.M., Eldelpshany, M.S., 2024. Intensive care unit (ICU)-related post-traumatic stress disorder: A literature review. Cureus 16(3), e57049.
• Alam, A., Thelin, E.P., Tajsic, T., Khan, D.Z., Khellaf, A., Patani, R., Helmy, A., 2020. Cellular infiltration in traumatic brain injury. Journal of Neuroinflammation 17(1), 328.
• Alvarez, S., Blanco, A., Fresno, M., Muñoz-Fernández, M.Á., 2011. TNF-α contributes to caspase-3 independent apoptosis in neuroblastoma cells: Role of NFAT. PLoS One 6(1), e16100.
• Bennett, M.R., 2002. Apoptosis in the cardiovascular system. Heart 87(5), 480-487.
• Cardona, A.E., Gonzalez, P.A., Teale, J.M., 2003. CC chemokines mediate leukocyte trafficking into the central nervous system during murine neurocysticercosis: role of gamma delta T cells in amplification of the host immune response. Infection and Immunity 71(5), 2634–2642.
• Cole, E., Gillespie, S., Vulliamy, P., Brohi, K., 2020. Organ dysfunction in trauma (ORDIT) study collaborators. Multiple organ dysfunction after trauma. The British Journal of Surgery 107(4), 402-412.
• Coppalini, G., Salvagno, M., Peluso, L., Bogossian, E.G., Quispe Cornejo, A., Labbé, V., Annoni, F., Taccone, F.S., 2024. Cardiac injury after traumatic brain injury: clinical consequences and management. Neurocritical Care 40(2), 477-485.
• Dekundy, A., Pichler, G., El Badry, R., Scheschonka, A., Danysz, W., 2024. Amantadine for traumatic brain injury—Supporting evidence and mode of action. Biomedicines 12(7), 1558.
• Dogrul, B.N., Kiliccalan, I., Asci, E.S., Peker, S.C., 2020. Blunt trauma-related chest wall and pulmonary injuries: An overview. Chinese Journal of Traumatology 23(3), 125-138.
• Elmore, S., 2007. Apoptosis: a review of programmed cell death. Toxicologic Pathology 35(4), 495-516. Garrido, C., Galluzzi, L., Brunet, M., Puig, P.E., Didelot, C., Kroemer, G., 2006. Mechanisms of cytochrome c release from mitochondria. Cell Death and Differentiation 13(9), 1423-1433.
• Guo, C., Sun, L., Chen, X., Zhang, D., 2013. Oxidative stress, mitochondrial damage and neurodegenerative diseases. Neural Regeneration Research 8(21), 2003-2014.
• Gyoneva, S., Ransohoff, R.M., 2015. Inflammatory reaction after traumatic brain injury: therapeutic potential of targeting cell-cell communication by chemokines. Trends in Pharmacological Sciences 36, 471-480.
• Hardeland, R., 2010. Investigational melatonin receptor agonists. Expert Opinion on Investigational Drugs 19(6), 747-764.
• Huang, C.H., Yang, C.T., Chang, C.C., 2023. Traumatic brain injury and risk of heart failure and coronary heart disease: A nationwide population-based cohort study. PLoS One 18(12), e0295416.
• Jiménez-Jiménez, F.J., Alonso-Navarro, H., García-Martín, E., Agúndez, J.A.G., 2020. Anti-inflammatory effects of amantadine and memantine: Possible therapeutics for the treatment of Covid-19? Journal of Personalized Medicine 10(4), 217.
• Khan, T., Waseem, R., Zehra, Z., Aiman, A., Bhardwaj, P., Ansari, J., Hassan, M.I., Islam, A., 2022. Mitochondrial dysfunction: Pathophysiology and mitochondria-targeted drug delivery approaches. Pharmaceutics 14(12), 2657.
• Kong, D.H., Kim, Y.K., Kim, M.R., Jang, J.H., Lee, S., 2018. Emerging roles of vascular cell adhesion molecule-1 (VCAM-1) in immunological disorders and cancer. International Journal of Molecular Sciences 19(4), 1057.
• Marmarou, A., Foda, M.A., van den Brink, W., Campbell, J., Kita, H., Demetriadou, K., 1994. A new model of diffuse brain injury in rats. Part I: Pathophysiology and biomechanics. Journal of Neurosurgery 80(2), 291-300.
• McIlwain, D.R., Berger, T., Mak, T.W., 2015. Caspase functions in cell death and disease. Cold Spring Harbor Perspectives in Biology 7(4), a026716.
• Morganti-Kossman, M.C., Lenzlinger, P.M., Hans, V., Stahel, P., Csuka, E., Ammann, E., Stocker, R., Trentz, O., Kossmann, T., 1997. Production of cytokines following brain injury: beneficial and deleterious for the damaged tissue. Molecular Psychiatry 2(2), 133-136.
• Mueller, K., Thiel, F., Beutner, F., Teren, A., Frisch, S., Ballarini, T., Möller, H.E., Ihle, K., Thiery, J., Schuler, G., Villringer, A., Schroeter, M.L., 2020. Brain damage with heart failure: Cardiac biomarker alterations and gray matter decline. Circulation Research 126(6), 750-764.
• Öcal, Ö., Coşar, A., Nazıroğlu, M., 2022. Amantadine attenuated hypoxia-induced mitochondrial oxidative neurotoxicity, apoptosis, and inflammation via the inhibition of TRPM2 and TRPV4 channels. Molecular Neurobiology 59(6), 3703-3720.
• Orhan, M., Taş Tuna, A., Ünal, Y., Arslan, M., Yazar, H., Sezen, Ş.C., Gözükara, S.I., Palabıyık, O., 2021. The effects of amantadine on lung tissue in lower limb ischemia/reperfusion injury model in rats. Turk Gogus Kalp Damar Cerrahisi Dergisi 29(1), 77-83.
• Qian, S., Wei, Z., Yang, W., Huang, J., Yang, Y., Wang, J., 2022. The role of BCL-2 family proteins in regulating apoptosis and cancer therapy. Frontiers in Oncology 12, 985363.
• Rachfalska, N., Putowski, Z., Krzych, Ł.J., 2020. Distant organ damage in acute brain injury. Brain Sciences 10(12), 1019.
• Ting, R.S., Lewis, D.P., Yang, K.X., Nguyen, T.A., Sarrami, P., Daniel, L., Hourigan, S., King, K., Lassen, C., Sarrami, M., Ridley, W., Alkhouri, H., Dinh, M., Balogh, Z.J., 2023. Incidence of multiple organ failure in adult polytrauma patients: A systematic review and meta-analysis. The Journal of Trauma and Acute Care Surgery 94(5), 725-734.
• Troncoso, M.F., Ortiz-Quintero, J., Garrido-Moreno, V., Sanhueza-Olivares, F., Guerrero-Moncayo, A., Chiong, M., Castro, P.F., García, L., Gabrielli, L., Corbalán, R., Garrido-Olivares, L., Lavandero, S., 2021. VCAM-1 as a predictor biomarker in cardiovascular disease. Biochimica et Biophysica Acta. Molecular Basis of Disease 1867(9), 166170.
• van der Bilt, I.A., Hasan, D., Vandertop, W.P., Wilde, A.A., Algra, A., Visser, F.C., Rinkel, G.J., 2009. Impact of cardiac complications on outcome after aneurysmal subarachnoid hemorrhage: a meta-analysis. Neurology 72, 635-642.
• Wenkang, W., Chuanjie, X., Xinglong, M., Xiaoming, Z., Peng, X., 2020. Intensive care unit-acquired weakness: A review of recent progress with a look toward the future. Frontiers in Medicine (Lausanne) 7, 559789.
• Wilson, E.H., Weninger, W., Hunter, C.A., 2010. Trafficking of immune cells in the central nervous system. The Journal of Clinical Investigation 120(5), 1368–1379.
• Zong, Y., Li, H., Liao, P., Chen, L., Pan, Y., Zheng, Y., Zhang, C., Liu, D., Zheng, M., Gao, J., 2024. Mitochondrial dysfunction: mechanisms and advances in therapy. Signal Transduction and Targeted Therapy 9(1), 124.
• Zygun, D., 2005. Non-neurological organ dysfunction in neurocritical care: impact on outcome and etiological considerations. Current Opinion in Critical Care 11, 139-143.